Clinical Trials Logo

Clinical Trial Summary

Percutaneous coronary intervention (PCI) has become one of the main treatments for rapid recovery of revascularization in patients with coronary heart disease (CHD). PCI has some advantages, such as easy operation, small trauma and rapid recovery. It can significantly improve myocardial ischemic symptom and reduce the incidence of cardiovascular adverse events in CHD patients. However, many studies have found that the incidence of PCI-related myocardial injury is relatively high, and affect the efficacy of PCI and prognosis in patients with unstable angina pectoris (UAP). A meta-analysis of a total of 7578 patients with UAP from 15 studies who underwent PCI was found to have a 28.7% increase in myocardial biomarkers after PCI. The objective of this randomized control trial is to gain a clinical insight on the use of low temperature contrast for the treatment of PCI-related myocardial injury in UAP patients. The primary objective is assess efficacy and safety of low temperature contrast for the treatment of PCI-related myocardial injury in UAP patients.


Clinical Trial Description

The current study is designed as a multicenter, randomized and prospective study aiming to compare the change in levels of myocardial injury biomarkers (such as TNI and CK-MB) between low temperature contrast group and room temperature contrast group. Based on previous study, the incidence rate of PCI-related myocardial injury is 28.7% in UAP patients undergoing PCI. And in our study the expected incidence rate of PCI-related myocardial injury is up to 14.3% in UAP patients undergoing PCI after treatment with low temperature contrast. Moreover, the investigators estimated 10% loss follow-up of these patients in each arm. As a result, a total of 440 UAP patients were required, and with 220 patients per group as a ratio of 1:1 randomization. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03700567
Study type Interventional
Source Nanjing First Hospital, Nanjing Medical University
Contact
Status Completed
Phase N/A
Start date August 1, 2018
Completion date July 1, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT01218776 - International Survey of Acute Coronary Syndromes in Transitional Countries
Completed NCT02612116 - Comparison of Administration Strategies of Ticagrelor in Patients With Unstable Angina Pectoris, a Pharmacokinetic / Pharmacodynamic Study Phase 4
Active, not recruiting NCT02508714 - Bioresorbable Polymer ORSIRO Versus Durable Polymer RESOLUTE ONYX Stents N/A
Completed NCT02939248 - Influence of Naloxone on Ticagrelor Pharmacokinetics and Pharmacodynamics in Patients With Unstable Angina Pectoris on Concomitant Treatment With Morphine Phase 4
Active, not recruiting NCT02175706 - DUrable Polymer-based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity N/A
Completed NCT01377402 - ARgentinean Risk Assessment Registry in ACS; the ARRA-RACS Study N/A
Completed NCT00521976 - Risk Markers in the Acute Coronary Syndromes
Completed NCT02144090 - Opsens Optowire for Fractional Flow Reserve - The O2 Pilot Study N/A
Completed NCT00627744 - Beta-cell Function in Glucose Abnormalities and Acute Myocardial Infarction Phase 4
Completed NCT00990262 - Rule Out Myocardial Infarction by Computer Assisted Tomography N/A
Enrolling by invitation NCT04008173 - The International Survey of Acute Coronary Syndromes-ARCHIVES
Withdrawn NCT02165670 - BASIC VALIDATE Coronary Stent Registry
Completed NCT01293097 - Intensive Statin Treatment in Chinese Coronary Artery Disease Patients Undergoing PCI Phase 4
Completed NCT01066650 - The Real-World Endeavor Resolute Versus XIENCE V Drug-Eluting Stent Study in Twente Phase 4
Completed NCT02747329 - A Comparative Evaluation of the Extent of Neointima Formation at 1 Month and 2 Months After Implantation Using OCT N/A
Completed NCT02939235 - Influence of Metoclopramide on Ticagrelor Pharmacokinetics and Pharmacodynamics in Patients With Unstable Angina Pectoris on Concomitant Treatment With Morphine Phase 4
Not yet recruiting NCT03155971 - PCB for Long De Novo Lesions of Main Coronary Arteries (D-Lesion Long Trial) N/A
Recruiting NCT04575207 - The Flash FFR Ⅱ Study N/A
Terminated NCT02235753 - High-intensity Exercise After Acute Cardiac Event (HITCARE) N/A
Completed NCT02007187 - Danhong Injection in the Treatment of Unstable Angina Pectoris Phase 4